Lunes 8am - 6pm Martes 8am - 6pm Miércoles 9am - 5pm Jueves 9am - 5pm Viernes 9am - 5pm Sábado 9am - 5pm

Medicovih

Consulta Medica Especializada para pacientes con infección por VIH
(servicio presencial y/o virtual).

19/07/2022

¿Con qué frecuencia deben hacerse pruebas de ITS a los usuarios de PrEP?

Dutch researchers have found that 79% of s*xually transmitted infections (STIs) diagnosed during PrEP users’ routine three-monthly checkups were asymptomatic. They also found that over half (52%) of these infections would have remained undiagnosed, and untreated, for an additional three months if ...

15/07/2022

Los datos australianos a nivel nacional muestran que la PrEP tiene un efecto mayormente neutral en la incidencia de ITS.

The largest study ever of the incidence of bacterial s*xually transmitted infections (STIs) among gay and bis*xual men who start HIV pre-exposure prophylaxis (PrEP) has found slight but statistically significant declines in chlamydia and gonorrhoea cases in the first couple of years after they start...

29/06/2022

Un estudio del 'mundo real' encuentra que la PrEP puede estar deteniendo el 60 % de las infecciones por VIH en hombres franceses con alto riesgo de contraer el VIH.

A study in France that matched new HIV diagnoses in adult men who had been taking PrEP with diagnoses in men at similar risk who had not been taking it, has found that the overall effectiveness of PrEP in stopping infection in this high-risk population was 60%. This 60% effectiveness figure included...

23/06/2022

Eficacia de la vacuna NVX-CoV2373 COVID-19 en pacientes con y sin VIH.

Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.

21/06/2022

Aumento sustancial de peso a medida que se implementa dolutegravir en África.

A study analysing data from four African countries found that people living with HIV who switched to a dolutegravir-based antiretroviral regimen had a four-fold increase in average weight gain, compared to the year before the switch.

17/06/2022

Un metanálisis revela la alta prevalencia mundial de la violencia de pareja entre las personas que viven con el VIH.

Four in ten people living with HIV have ever experienced intimate partner violence, with two in ten people experiencing it in the previous year. This is according to the results of a systematic review and meta-analysis published in Trauma, Violence, & Abuse. Emotional abuse was the most prevalen...

16/05/2022

Fluconazol versus otros antimicóticos para la candidiasis esofágica en pacientes con VIH.

In this meta-analysis, researchers assessed the safety and efficacy of fluconazole compared with alternative antifungal agents for the treatment of esophageal candidiasis.

09/05/2022

Resultados, seguridad de la bedaquilina basada en el peso en niños con tuberculosis resistente a múltiples fármacos.

Researchers assessed the pharmacokinetic profile and safety of weight-based bedaquiline among children with multidrug-resistant tuberculosis.

07/05/2022

Injectable Cabotegravir: Effective, May Overcome Challenges of Daily HIV Pre-Exposure Prophylaxis for Women

Researchers compared the safety and efficacy of injectable cabotegravir vs oral tenofovir diphosphate plus emtricitabine for the prevention of HIV infection among women.

05/05/2022

Resultados perinatales similares entre diferentes regímenes antirretrovirales basados en inhibidores de la proteasa.

Investigators assessed whether treatment with protease inhibitor-based antiretroviral therapy during pregnancy increases the risk for poor perinatal outcomes among women with HIV infection.

04/05/2022

Obtenga su vacuna COVID de refuerzo de primavera, la Asociación Británica del VIH aconseja a todas las personas con VIH.

The British HIV Association (BHIVA) recently updated its guidance on COVID vaccinations for people with HIV to align with the recommendation by the UK's Joint Committee on Vaccination and Immunisation (JCVI) that people aged 12 years and over who are immunosuppressed, including all people with....

29/04/2022

Los expertos recomiendan la quinta vacuna contra el COVID-19 para personas inmunocomprometidas.

National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer.

28/04/2022

The COVID-19 pandemic disrupted HIV prevention and care in Barcelona, but new cases and viral loads didn’t increase.

In-person healthcare visits related to HIV prevention and care decreased in number at the largest HIV care centre in Spain as a result of lockdowns during the COVID-19 pandemic. While chlamydia and gonorrhoea cases surged in 2020 compared to 2019, new HIV cases decreased by 28%. But the new HIV case...

27/04/2022

Índice de masa corporal bajo al inicio del tratamiento y resultados del tratamiento de la tuberculosis resistente a la rifampicina: metanálisis de datos de un participante individual.

AbstractBackground. The impact of low body-mass-index at treatment initiation on rifampicin-resistant tuberculosis treatment outcomes is uncertain. We evaluated

25/04/2022

Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder.

Researchers assessed whether computerized cognitive training programs were associated with improvements in overall cognitive and daily function in patients with HIV infection.

23/04/2022

Cuatro de cada diez beneficiarios de la PrEP dejan de tomarla en un plazo de seis meses, según revela un metanálisis mundial.

A meta-analysis of 59 studies of PrEP from all continents has found that 41% of people who started taking PrEP had discontinued it within six months. Discontinuation rates were much higher in studies for all groups other than gay and bis*xual men and trans women, including female s*x workers, people...

21/04/2022

Anuncio del tema del Día Nacional de la Prueba del VIH 2022.

Dear National HIV Testing Day Partners,On June 27th each year, we observe National HIV Testing Day (NHTD), a day to emphasize and encourage HIV testing. This year, we observe NHTD as COVID-19 and HIV epidemics continue to affect our communities, the nation, public health departments, and healthcare....

Dirección

Carrera 29 # 47-108 Consultorio 7 Piso 2, Centro Medico De Especialistas SOMES
Bucaramanga
680003

Horario de Apertura

Lunes	8am - 6pm
Martes	8am - 6pm
Miércoles	9am - 5pm
Jueves	9am - 5pm
Viernes	9am - 5pm
Sábado	9am - 5pm

Teléfono

+573158498366

Página web

http://www.medicovih.com/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Medicovih publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.